Suppr超能文献

中国和其他亚洲国家多发性硬化症的发病率和患病率。

Incidence and prevalence of multiple sclerosis in China and other Asian countries.

机构信息

Unidad de Esclerosis Múltiple. Servicio de Neurología. Hospital Vithas-Nisa, Sevilla, España; Instituto de Biomedicina de Sevilla, IBiS (Universidad de Sevilla, HUVR, Junta de Andalucía, CSIC) y Departamento de Bioquímica Médica y Biología Molecular e Inmunología, Universidad de Sevilla, Sevilla, España.

Instituto de Biomedicina de Sevilla, IBiS (Universidad de Sevilla, HUVR, Junta de Andalucía, CSIC) y Departamento de Bioquímica Médica y Biología Molecular e Inmunología, Universidad de Sevilla, Sevilla, España.

出版信息

Neurologia (Engl Ed). 2023 Apr;38(3):159-172. doi: 10.1016/j.nrleng.2020.07.022.

Abstract

The prevalence of multiple sclerosis (MS) in Asian countries is thought to be lower than in Western countries, with Asian populations presenting 80% less risk of MS than white populations. Incidence and prevalence rates in Asian countries are therefore not well defined and their association with rates in neighboring countries, as well as with ethnic, environmental, and socioeconomic factors, are not well understood. We performed a comprehensive literature review of epidemiological data from China and neighbouring countries to study the frequency of the disease, focusing on prevalence, and the progression over time and the influence of sex-related, environmental, dietary, and sociocultural factors. Prevalence rates in China range between 0.88 cases/100,000 population in 1986 and 5.2 cases/100,000 population in 2013, with a non-significant upwards trend (p = .08). The increase observed in Japan, where figures ranged between 8.1 and 18.6 cases/100,000 population was highly significant (p < .001). Prevalence rates in countries with predominantly white populations are considerably higher and have increased over time, reaching 115 cases/100,000 population in 2015 (r = 0.79, p < .0001). In conclusion, the prevalence of MS in China appears to have risen in recent years, although Asian populations (including Chinese and Japanese populations, among others) appear to present less risk than other populations. Within Asia, geographical latitude appears not to be a determining factor for developing MS.

摘要

多发性硬化症(MS)在亚洲国家的发病率被认为低于西方国家,亚洲人群患 MS 的风险比白种人群低 80%。因此,亚洲国家的发病率和患病率尚不清楚,其与邻国的发病率以及与种族、环境和社会经济因素的关系也不清楚。我们对来自中国和邻国的流行病学数据进行了全面的文献回顾,以研究疾病的频率,重点是患病率,以及随着时间的推移的进展,以及性别相关、环境、饮食和社会文化因素的影响。中国的患病率范围在 1986 年的 0.88 例/100,000 人口和 2013 年的 5.2 例/100,000 人口之间,呈非显著上升趋势(p =.08)。在日本,患病率从 8.1 例/100,000 人口到 18.6 例/100,000 人口的上升趋势非常显著(p <.001)。以白种人为主的国家的患病率明显较高,且呈上升趋势,2015 年达到 115 例/100,000 人口(r = 0.79,p <.0001)。总之,近年来中国的 MS 患病率似乎有所上升,尽管亚洲人群(包括中国和日本人群等)的患病风险似乎低于其他人群。在亚洲内部,地理位置似乎不是患 MS 的决定因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验